15 filings
6-K
CMMB
Chemomab Therapeutics Ltd
21 Nov 19
Consolidated Interim Financial Statements
5:00pm
6-K
CMMB
Chemomab Therapeutics Ltd
15 Nov 19
Current report (foreign)
8:58am
6-K
CMMB
Chemomab Therapeutics Ltd
12 Nov 19
Current report (foreign)
5:02pm
6-K
CMMB
Chemomab Therapeutics Ltd
28 Oct 19
Current report (foreign)
6:50am
6-K
CMMB
Chemomab Therapeutics Ltd
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
6-K
tpipu
13 Aug 19
Consolidated Interim Financial Statements
5:15pm
6-K
z047ndfjig
6 Aug 19
Anchiano Therapeutics Reports Second Quarter 2019 Financial Results
9:15am
6-K
euck6fbzb43o0l
8 Jul 19
Current report (foreign)
7:30am
6-K
5i84joqax4woajk
18 Jun 19
Current report (foreign)
8:30am
6-K
z2bi4l8o
28 May 19
Notice of Annual General Meeting of Shareholders of the Company
5:26pm
6-K
wshz5
22 May 19
Anchiano Therapeutics Reports First Quarter 2019 Financial Results
9:00am
6-K
cuq8a1c 9eod1qt
14 Mar 19
Current report (foreign)
7:00am
6-K
ikhpkd73ogf64z1
12 Mar 19
Anchiano Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
4:15pm
6-K
21pdw
14 Feb 19
Current report (foreign)
4:40pm
6-K
t4ybvt5oxg
12 Feb 19
Current report (foreign)
9:15am
- Prev
- 1
- Next